You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 14, October 8, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Venous Thromboembolism
 •Cardiovascular System
 •Renal Diseases
 •Dialysis
 •Surgery
 •Surgical Interventions
 •Vascular Surgery
 •Prognosis/ Outcomes
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Effect of Clopidogrel on Arteriovenous Fistulas for Dialysis

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The trial by Dr Dember and colleagues1 failed to show any improvement in fistula maturation for hemodialysis by using clopidrogrel, although its use decreased the frequency of early thrombosis. However, the design of the study might explain some of the results.

Successful arteriovenous fistula creation depends on many important factors. First, there must be adequate predialysis care, particularly protection of the veins from unnecessary cannulations for blood sampling or for intravenous administration of fluids and medications; this was not described. Second, there must be appropriate preoperative evaluation of the arterial and venous networks by methods such as x-rays for possible detection of calcifications of the arteries, Doppler ultrasound for arteries and veins, or venography.2 Although Dember et al report that vascular mapping was performed in almost 75% of the patients,1 they do not provide extensive data. It would be interesting to explore whether mapping presented any advantage, . . . [Full Text of this Article]

Costas Fourtounas, MD, PhD
cfourt@usa.net

Jannis G. Vlachojannis, MD
Department of Internal Medicine–Nephrology
Patras University Hospital
Rio-Patras, Greece



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Effect of Clopidogrel on Early Failure of Arteriovenous Fistulas for Hemodialysis: A Randomized Controlled Trial
Laura M. Dember, Gerald J. Beck, Michael Allon, James A. Delmez, Bradley S. Dixon, Arthur Greenberg, Jonathan Himmelfarb, Miguel A. Vazquez, Jennifer J. Gassman, Tom Greene, Milena K. Radeva, Gregory L. Braden, T. Alp Ikizler, Michael V. Rocco, Ingemar J. Davidson, James S. Kaufman, Catherine M. Meyers, John W. Kusek, Harold I. Feldman, and for the Dialysis Access Consortium Study Group
JAMA. 2008;299(18):2164-2171.
ABSTRACT | FULL TEXT  

RELATED LETTERS

Effect of Clopidogrel on Arteriovenous Fistulas for Dialysis
Raghav Wusirika and Panduranga Rao
JAMA. 2008;300(14):1647.
EXTRACT | FULL TEXT  

Effect of Clopidogrel on Arteriovenous Fistulas for Dialysis
Dirk M. Hentschel and Arif Asif
JAMA. 2008;300(14):1647-1648.
EXTRACT | FULL TEXT  

Effect of Clopidogrel on Arteriovenous Fistulas for Dialysis—Reply
Laura M. Dember, Gerald J. Beck, and Harold I. Feldman
JAMA. 2008;300(14):1648-1649.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.